Effects of Nifedipine on Blood Pressure, Arterial Compliance and Left Ventricular Mass in Elderly Patients with Isolated Systolic Hypertension
The aim of this study was to evaluate the effects of acute and chronic administration of slow-release nifedipine (SRN) on blood pressure (BP), aortic index (AI), average wall stress (AWS), left ventricular mass (LVM), and other hemodynamic parameters in elderly patients with isolated systolic hypertension (ISH) (systolic blood pressure [SBP] > 175 mmHg). We studied 10 patients (mean age 73.7 ± 5.6 years) in which after a washout period, in basal conditions, 3 h after the administration of SRN (20 mg), and 180 days after chronic therapy (40 mg daily), we evaluated the changes of BP, HR, AI, AWS, LVM, and other parameters obtained by means of echocardiography. After SRN we observed a significant decrease of SBP both in acute (P < 0.005 in supine and P < 0.0125 in upright position) and in chronic (P < 0.0005 in supine and P < 0.005 in upright position) therapies and a slight decrease of DBP, whereas HR did not show great changes. AI decreased significantly (P < 0.01 in acute and in chronic) as well as did systemic vascular resistance (P < 0.025 in acute and P < 0.01 in chronic). Moreover, we observed a significant diminution of AWS (P < 0.01) and LVM (P < 0.01) after 180 days of treatment. These results seem to show that SRN is useful in elderly patients with ISH, because it produces an improvement both of arterial compliance and of left ventricle function parameters.
KeywordsSystolic Blood Pressure Calcium Antagonist Systolic Hypertension Arterial Compliance Shorten Fraction
Unable to display preview. Download preview PDF.
- 1.Kannel WB, Gordon T (1978) Evaluation of cardiovascular risk in the elderly: The Framingham Study. Bull NY Acad Med 54: 573–591Google Scholar
- 2.Subcommittee on Risk Factors and Stroke of the Stroke Council (1987) Risk factors in stroke. AHA Focus Series. American Heart Association. Stroke 3 (1): 9–14Google Scholar
- 4.Simon ACh. Safer ME, Levenson JA, London GM, Levy BI, Chau NPh (1979) An evaluation of large arteries compliance in man. AM J Physiol 237: 550–554Google Scholar
- 7.Anonymous (1985) Treatment of hypertension in the over-60s. Lancet 1: 1369–1370 (editorial)Google Scholar
- 8.Laragh JH, Bühler FR, Chobanian A, Hansson L, Zachariah PK (1987) Calcium antagonists in hypertension: update 1986. J Cardiovasc Pharmacology 9 (Suppl IV): 1–3Google Scholar
- 11.MacGregor GA (1986) Hypertension. In: Krebs R (ed) Treatment of cardiovascular diseases by Adalat (nifedipine). Schattauer, Stuttgart New York, pp 231–258Google Scholar
- 16.Tarazi RC, Magrini F, Dustan HP (1975) The role of aortic distensibility in hypertension. In: Miller P, Safar MD (eds) International symposium on hypertension. Boehringer Ingelheim, Monaco, pp 133–138Google Scholar
- 17.Novo S, Licata G, Pinto A, Davi G, Strano A (1983) Haemodynamic effects of an antihypertensive combination between labetalol and chlortalidone administered for 6 months. J Hypertens 1 (Suppl II): 353–360Google Scholar
- 22.Fleckenstein A (1988) Future prospects in calcium antagonist therapy: prevention of arteriosclerotic vascular damage. Abstract of Verapamil Satellite Symposium of the 25 Anniversary International Symposium on Calcium Antagonists in Hypertension, Basel, February 9–11, 1988. p3Google Scholar